Secondary Tumor

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Focus on the World Chitin & Chitosan Market

Published December 4, 2008, 4:19 am, Business Wire via Yahoo! Finance

NEW YORK----Reportlinker.com announces that a new market research report related to the Chemicals industry industry is available in its catalogue.

Discover News | Full Story


Key Challenges and Issues facing the World Immunoassay Instruments Market

Published December 4, 2008, 4:07 am, Business Wire via Yahoo! Finance

NEW YORK----Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

Discover News | Full Story


Morphotek initiates Phase II ovarian cancer study

Published December 4, 2008, 3:10 am, Pharmaceutical Business Review

Morphotek, a subsidiary of Eisai Corporation of North America, has started a multi-centered Phase II study of farletuzumab. The study will evaluate farletuzumab, plus the chemotherapy drug paclitaxel, in patients with platinum-resistant ovarian cancer.

Discover News | Full Story


Sports Briefs - December 4, 2008

Published December 3, 2008, 8:47 pm, Cumberland Times-News

BALTIMORE — Saturday at noon, the Fort Hill Sentinels will play the Dunbar Poets for the Maryland Class 1A state football championship. The following directions to M&T Bank Stadium in Baltimore can be found on the Maryland Public Secondary Schools Athletic Association web site, www.mpssaa.org:

Discover News | Full Story


Technology brings increased efficiency, accuracy in mammography results

Published December 3, 2008, 6:01 am, West Orange Times

"It was my obstetrician gynecologist (OB/GYN) that found the lump in my breast and sent me for a diagnostic mammogram and ultrasound. A few weeks later, I received a letter from the imaging center that did the mammogram and they said it was normal and to come back in a year.

Discover News | Full Story


Questions/Answers

Published December 2, 2008, 11:51 pm, Inland Valley Daily Bulletin

Questions and answers on Daily Bulletin stories from readers like you. The Folga golf group, established by Joe Toledo of Chino to share friendships and to raise funds for City of Hope cancer research, will hold its club championship Sunday at Los Serranos South.

Discover News | Full Story


Dr. William Tierney remembered as humanitarian

Published December 2, 2008, 5:21 pm, The Herald Bulletin

ANDERSON — A prominent, retired Anderson surgeon was identified Tuesday as the driver who died in a crash while taking himself to an emergency room a day earlier.Dr. William J. Tierney, 74, was pronounced dead at Community Hospital shortly after his car was involved in a single-vehicle accident on Vanbuskirk Road in Anderson at 5:44 p.m. Monday.

Discover News | Full Story


Two Studies Show Benefits Of Removing Tumor Tissue In The Spine Prior To Adjuntive Treatments

Published December 2, 2008, 9:13 am, Medical News Today

Two studies, presented this week at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), concluded a novel technique can improve outcomes for patients with vertebral compression fractures (VCF) caused by malignant tumors in the spine.

Discover News | Full Story


Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer

Published December 2, 2008, 6:35 am, Centre Daily Times

Morphotek ® , Inc., a subsidiary of Eisai Corporation of North America, today announced that it has commenced a multi-centered Phase II study of farletuzumab (also known as MORAb-003). The study will evaluate farletuzumab, plus the chemotherapy drug paclitaxel, in patients with platinum-resistant (PR) ovarian cancer. The randomized, controlled trial will compare farletuzumab plus paclitaxel with ...

Discover News | Full Story


Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer

Published December 2, 2008, 6:00 am, Business Wire via Yahoo! Finance

EXTON, Pa.----Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, today announced that it has commenced a multi-centered Phase II study of farletuzumab . The study will evaluate farletuzumab, plus the chemotherapy drug paclitaxel, in patients with platinum-resistant ovarian cancer.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a